.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Argus Health
Mallinckrodt
Express Scripts
Medtronic
Federal Trade Commission
Chubb
Citi
Healthtrust
Queensland Health

Generated: July 26, 2017

DrugPatentWatch Database Preview

Kremers Urban Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for KREMERS URBAN PHARMS, and what generic and branded alternatives to KREMERS URBAN PHARMS drugs are available?

KREMERS URBAN PHARMS has eighteen approved drugs.

There is one tentative approval on KREMERS URBAN PHARMS drugs.

Summary for Applicant: Kremers Urban Pharms

Patents:0
Tradenames:16
Ingredients:15
NDAs:18
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kremers Urban Pharms
ISOSORBIDE MONONITRATE
isosorbide mononitrate
TABLET, EXTENDED RELEASE;ORAL075155-002Jan 13, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe
Kremers Urban Pharms
PANTOPRAZOLE SODIUM
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL078281-001Jan 20, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Kremers Urban Pharms
OMEPRAZOLE
omeprazole
CAPSULE, DELAYED REL PELLETS;ORAL075410-003Jan 23, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Kremers Urban Pharms
ATORVASTATIN CALCIUM
atorvastatin calcium
TABLET;ORAL091624-004Apr 5, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Kremers Urban Pharms
OMEPRAZOLE
omeprazole
CAPSULE, DELAYED REL PELLETS;ORAL075410-001Nov 1, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for KREMERS URBAN PHARMS drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazole
Delayed-release Tablets20 mg
OMEPRAZOLE
6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
UBS
Chubb
Teva
Healthtrust
Fuji
Boehringer Ingelheim
Julphar
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot